Given this background, separate studies observed that 10% of women diagnosed with breast cancer and approximately 30% of patients diagnosed with a wide range of cancers had detectable and quite specific antibodies against p53, correlated with cancers carrying p53 missense mutations [10]. This evidence concerns the gene TP53 and cancer.